List your company

Precision Cirrhosis

Diagnostics and imaging · by InVision Medical Technology

Opportunistic screening for cirrhosis and steatotic liver disease from the subcostal view captured during routine echocardiography.

Visit website

What it does

Opportunistic screening for cirrhosis and steatotic liver disease from the subcostal view captured during routine echocardiography. Applies deep learning to the subcostal echo view to screen for cirrhosis and steatotic liver disease — no additional imaging or patient time required. Built on the EchoNet-Liver pipeline, developed from over 1.5 million echocardiogram videos and validated against paired abdominal ultrasound and MRI studies at two large academic medical centers. In development; an AHA-funded prospective multi-center validation trial is underway.

  • Automated echocardiographic LVEF measurement
  • AI screening for cardiac amyloidosis
  • Opportunistic liver disease screening from echocardiography
  • Automated structured echocardiographic report generation
  • Multi-valve disease detection (mitral, tricuspid, aortic)
  • Automatic DICOM deidentification for research and data sharing
Category
Diagnostics and imaging
Built for
Healthcare and life sciences
Users
Health systems, Cardiovascular service lines, Echo labs, Data teams building research or AI training datasets
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

InVision Medical Technology doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by InVision Medical Technology. Ask for audit reports before you buy.

  • SOC 2Compliant
  • ISO 9001Compliant
  • HIPAACompliant
  • FDA 510(k) Clearance — Precision LVEFCompliant
  • FDA 510(k) Clearance — Precision Cardiac AmyloidCompliant
  • FDA Breakthrough Device Designation — Precision Cardiac AmyloidCompliant
  • FDA Breakthrough Device Designation — Precision CirrhosisCompliant
  • FDA Total Product Lifecycle Advisory Program (TAP) — Precision Cardiac AmyloidCompliant
  • CPT Category III code 0932T (effective January 1, 2025) — Precision Cardiac AmyloidCompliant
  • DICOM Part 15 compliance — Automatic DICOM DeidentificationCompliant
  • Session-only cookies (no persistent cookies)
  • Commercially reasonable physical, managerial, and technical safeguards
  • Security breach notification to affected users
  • Third-party processors required to use reasonable confidentiality measures and comply with Privacy Policy

Reviews

No reviews yet

Reviews come from people who use Precision Cirrhosis at work. Share how your team uses it to help other buyers decide.

Write a review

Alternatives

  • Instalab Blood Panel

    by Instalab

    Comprehensive blood test that detects hidden risks and early warning signs of disease in all your body's key systems: cardiovascular, metabolic, liver, kidneys, thyroid, and more.

  • Referral Portal

    by AlemHealth

    Seamless study sharing and incoming orders between referring physicians and imaging centers.

  • Cardiology Solution

    by Aidoc

    Imaging and text-based AI insights to automatically measure disease and capture incidental cardiac findings such as coronary artery disease and echocardiography.

  • LDCT

    by Instalab

    A specialized CT scan that finds early lung cancer in current and former smokers, improving outcomes through early treatment.

  • Imaging

    by Perceptive

    Handheld intraoral scanner using advanced OCT technology to capture 3D volumetric data including below the gum line, through fluids, and under the tooth surface, without ionizin...

  • Scanbase Platform

    by Scanbase, Inc.

    Platform for converting photos of rapid diagnostic tests into positive or negative results, with a module-based pricing calculator covering selected diagnostic modules.

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Precision Cirrhosis